En Helicobacter pylori. Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Conditions
Interventions
Intervention 1: Intervention group 1: 14-day quadruple regimen including "Bismuth subcitrate manufactured by Kamidaroo 240 mg 2 times daily, pantazol 40 mg twice daily by Nycomed, amoxicillin made by
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Positive Helicobacter pylori in the endoscopy No therapeutic regimen for treatment People over the age of 18 years
Exclusion criteria
Exclusion criteria: Pregnant and breast feeding women Gastric and esophageal malignancy Cirrhosis and Diabetes heart and kidney failure History of seizure, hematologic diseases Immune system deficiency Drug sensitivity including Pentoprazole and Lactobacillus routeri Patients with incomplete treatment With acute gastrointestinal disease (such as acute diarrhea) Chronic gastrointestinal disease (such as inflammatory bowel disease and celiac disease) Kidney failure Nervous disease and those who received antibiotics or acidblocking drugs 6 weeks ago Use of nonsteroidal antiinflammatory drugs (NSAIDs) such as aspirin 3 weeks before treatment or in the past month for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori eradication. Timepoint: 8 weeks after the end of the treatment. Method of measurement: En Ureas Breath Test with C14. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Fariborz Mansour-Ghanei
Rasht University of Medical Sciences
Outcome results
None listed